Test Price
2,800 AED✅ Home Collection Available
SLC2A9 Gene Hypouricemia, Renal Type 2 Genetic Test in UAE | 2800 AED | DHA Certified
Executive Summary & Core Metrics
- Analytical Sensitivity: 99.9% diagnostic accuracy via ISO 15189 accredited NGS workflow.
- Logistics Excellence: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic genetic counselling included for comprehensive result interpretation.
- Insurance & Billing: Direct verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SLC2A9 gene NGS test identifies pathogenic variants responsible for renal hypouricemia type 2, a rare metabolic disorder that can cause exercise-induced acute kidney injury and nephrolithiasis. This comprehensive assay detects single nucleotide variants, insertions, deletions, and splice-site aberrations across the entire coding region with 99.9% analytical sensitivity and specificity. Early molecular diagnosis enables targeted lifestyle modifications to prevent renal complications in at-risk individuals.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | Full gene NGS (coding + splice sites) | Limited targeted panel / single variant |
| Methodology | Next-Generation Sequencing (Illumina NovaSeq) | Sanger sequencing (single exon) |
| Turnaround | 3 – 4 Weeks | 4 – 6 Weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I underscore that the SLC2A9 gene test should be interpreted within the full clinical context including serum uric acid levels, fractional excretion of urate, and a three-generation pedigree. A negative molecular result does not exclude alternative etiologies of hypouricemia. This precision diagnostic empowers proactive prevention of exercise-induced acute kidney injury and tailored family counselling.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety & Advisory Notice
Critical Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. This genetic test is not a substitute for a physician's clinical assessment.
Exclusion Criteria – Do Not Proceed If:
- Patient is under 18 years without valid legal guardian consent.
- Acute febrile illness or uncontrolled metabolic crisis present.
- Inability to provide a valid three-generation clinical history or pedigree chart.
Emergency Red Flags – Immediate Medical Attention Required:
- Sudden severe flank pain or anuria following physical exertion.
- Unexplained nausea, vomiting, or confusion with documented low serum uric acid.
- Signs of acute kidney injury including oliguria, peripheral swelling, and fatigue.
Patient FAQ & Clinical Guidance
1. What exactly does the SLC2A9 genetic test diagnose?
SLC2A9 gene testing accurately identifies mutations linked to renal hypouricemia type 2, enabling targeted prevention of exercise-induced kidney complications. This NGS assay covers the entire coding region and splice junctions of the SLC2A9 gene, distinguishing pathogenic variants from benign polymorphisms with 99.9% analytical sensitivity. It is the definitive molecular diagnosis for patients with unexplained low serum uric acid (below 2.0 mg/dL) and family history of kidney dysfunction or nephrolithiasis.
2. How should I prepare for the test and what sample is required?
A simple blood draw using EDTA or lithium heparin tubes, extracted DNA, or a single drop on an FTA card is sufficient for analysis. You must complete a pre-test genetic counselling session to construct a detailed three-generation pedigree chart documenting all family members with hypouricemia or kidney stones. No fasting is required, however inform our clinical team of all medications and supplements as certain drugs can alter uric acid levels and must be documented in the clinical history.
3. Is this test covered by UAE health insurance and what does the price include?
The all-inclusive fee of 2800 AED covers VIP mobile phlebotomy with temperature-controlled cold-chain logistics, full NGS gene analysis, and a telephonic post-test consultation with a genetics specialist. Most UAE insurers cover genetic testing for hypouricemia when medically necessary; our billing team verifies direct coverage via WhatsApp at +971 54 548 8731. You will receive a detailed clinically actionable report within 3 to 4 weeks from sample receipt.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
- All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) ensuring patient confidentiality and data sovereignty.
- Health information systems adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for secure electronic health records.
- Clinical testing safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability ensuring ethical medical practice.
- Laboratory operations are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) with full DHA licensing.
Clinical & Logistical Metadata
| Test Name | SLC2A9 Gene Hypouricemia, Renal Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA / Lithium Heparin), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Analysis (Coding Region & Splice Junctions) |
| ICD-10-CM Code | E79.8 (Other disorders of purine and pyrimidine metabolism) |
| LOINC Code | 82126-0 (SLC2A9 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians